This finding is in contrast to established evidence demonstrating an increase in plasma PAI-1 activity and impaired fibrinolysis in cardiovascular diseases (Gils & Declerck, 2004; Hamsten et al., 1987; Juhan-Vague et al., 1987; Vaughan, 2005). Here, SERPINE1 is linked to cardiovascular disorder.